In contrast to other countries as USA, Australia and some european countries there are no german studies concerning psychiatric disordes in runaway and homeless children and adolescents. Although the presence of street youths faces a big problem, there is a deficit of empirical data among this gro...
Australia South Korea Rest of Asia-Pacific Middle East and Africa GCC South Africa Rest of Middle East and Africa South America Brazil Argentina Rest of South America Need A Different Region Or Segment? Customize Now Drug Discovery Market Research FAQs ...
She completed her PhD in illicit drug research in 1999 and was subsequently involved with the inception of Australia's Illicit Drug Reporting System. She has a long-standing interest in researching methamphetamine and other amphetamine-type stimulant substances and has consulted to the UN office on ...
Australia Latin America Brazil Mexico Middle East Asia & Africa South Africa GCC Countries Authors:Mariam Faizullabhoy , Frequently Asked Question(FAQ) : What was the size of the global drug of abuse testing market in 2018? The market size of home drug of abuse testing crossed USD 3.3 billion...
Annual performance statistics report 2019-20. ACT, Australia: Therapeutic Goods Administration; 2020. Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK “Yellow Card Scheme”: literature review, ...
Yu VY. Neonatal sepsis and infection control policies in Australia. Journal of Paediatric and Child Health 26: 252–256, 1990 Article CAS Google Scholar Download references Author information Authors and Affiliations Department of Paediatrics, Medical University of Lübeck, Kahlhorststrasse 31-35, D...
Teesson MBaillie ALynskey MManor BDegenhardt L Substance use, dependence and treatment seeking in the United States and Australia: a cross-national comparison. Drug Alcohol Depend 2006;81149- 155PubMedGoogle ScholarCrossref 69. Warner LAKessler RCHughes MAnthony JCNelson CB Prevalence and correlat...
Given the risks associated with APs (Melkersson et.al, 2004), regular review of their use in the clinical setting is warranted to optimize the quality use of these medicines and minimize iatrogenic harm.Fares Al-SarawiDaw ParkSouth ...
(ATC B02), while in Australia and Slovenia they are respiratory system products (ATC R07) and in South African Republic they are immunosuppressants (ATC L04), hematological agents (ATC B06) and alimentary tract and metabolism products (ATC A16). These partial results are shown in Table4, ...
The concern has been raised against the phthalates by many countries like the US, China, Australia, and Europe where DEHP, DEP, DINP, di-isodecyl phthalate (DIDP), and dioctyl phthalate (DnOP) were banned in many food applications and household items (Wang and Qian, 2021). In many pharmace...